A citation-based method for searching scientific literature

Ling Gao, Pi-Xiao Wang, Yaxing Zhang, Chang-Jiang Yu, Yanxiao Ji, Xiaozhan Wang, Peng Zhang, Xi Jiang, Hong Jin, Zan Huang, Zhi-Ren Zhang, Hongliang Li. J Hepatol 2016
Times Cited: 36







List of co-cited articles
558 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Pi-Xiao Wang, Xiao-Jing Zhang, Pengcheng Luo, Xi Jiang, Peng Zhang, Junhong Guo, Guang-Nian Zhao, Xueyong Zhu, Yan Zhang, Sijun Yang,[...]. Nat Commun 2016
94
66

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Mei Xiang, Pi-Xiao Wang, Ai-Bing Wang, Xiao-Jing Zhang, Yaxing Zhang, Peng Zhang, Fang-Hua Mei, Man-Hua Chen, Hongliang Li. J Hepatol 2016
96
63

Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Xin-An Wang, Ran Zhang, Zhi-Gang She, Xiao-Fei Zhang, Ding-Sheng Jiang, Tao Wang, Lu Gao, Wei Deng, Shu-Min Zhang, Li-Hua Zhu,[...]. Hepatology 2014
108
44

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
Yan-Xiao Ji, Peng Zhang, Xiao-Jing Zhang, Yi-Chao Zhao, Ke-Qiong Deng, Xi Jiang, Pi-Xiao Wang, Zan Huang, Hongliang Li. Nat Commun 2016
117
44

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.
Pi-Xiao Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Ling-Ping Zhao, Zhen-Zhen Yan, Peng Zhang, Li-Jun Shen, Xia Yang, Jing Fang, Song Tian,[...]. Nat Med 2017
142
44

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
Guang-Nian Zhao, Peng Zhang, Jun Gong, Xiao-Jing Zhang, Pi-Xiao Wang, Miao Yin, Zhou Jiang, Li-Jun Shen, Yan-Xiao Ji, Jingjing Tong,[...]. Nat Med 2017
93
44

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Lanfeng Xie, Pi-Xiao Wang, Peng Zhang, Xiao-Jing Zhang, Guang-Nian Zhao, Aibing Wang, Junhong Guo, Xueyong Zhu, Qin Zhang, Hongliang Li. J Hepatol 2016
47
41

Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice.
Xin-An Wang, Ran Zhang, Dingsheng Jiang, Wei Deng, Shumin Zhang, Shan Deng, Jinfeng Zhong, Tao Wang, Li-Hua Zhu, Li Yang,[...]. Hepatology 2013
64
33

The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis.
Feng-Juan Yan, Xiao-Jing Zhang, Wen-Xin Wang, Yan-Xiao Ji, Pi-Xiao Wang, Yang Yang, Jun Gong, Li-Jun Shen, Xue-Yong Zhu, Zan Huang,[...]. Hepatology 2017
52
33

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Junfei Hu, Xue-Hai Zhu, Xiao-Jing Zhang, Pi-Xiao Wang, Ran Zhang, Peng Zhang, Guang-Nian Zhao, Lu Gao, Xiao-Fei Zhang, Song Tian,[...]. J Hepatol 2016
70
33

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.
Peng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, Xin Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Chun Fang, Yue-Xin Lu, Xia Yang, Mao-Mao Gao,[...]. Nat Med 2018
118
30

TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.
Anna Missiou, Philipp Rudolf, Peter Stachon, Dennis Wolf, Nerea Varo, Peter Aichele, Christian Colberg, Natalie Hoppe, Sandra Ernst, Christian Münkel,[...]. Circ Res 2010
40
25

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
25

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
Yan-Xiao Ji, Zan Huang, Xia Yang, Xiaozhan Wang, Ling-Ping Zhao, Pi-Xiao Wang, Xiao-Jing Zhang, Michele Alves-Bezerra, Lin Cai, Peng Zhang,[...]. Nat Med 2018
79
25

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
Xin-An Wang, Ran Zhang, Shumin Zhang, Shan Deng, Dingsheng Jiang, Jinfeng Zhong, Li Yang, Tao Wang, Shufen Hong, Sen Guo,[...]. Am J Physiol Endocrinol Metab 2013
69
22

Interferon regulatory factor signalings in cardiometabolic diseases.
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Hypertension 2015
40
22

Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis.
Zhouyan Bian, Jia Dai, Nakano Hiroyasu, Hongjing Guan, Yuan Yuan, Lihua Gan, Heng Zhou, Jing Zong, Yan Zhang, Fangfang Li,[...]. J Cell Biochem 2014
23
34

Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury.
Pi-Xiao Wang, Ran Zhang, Ling Huang, Li-Hua Zhu, Ding-Sheng Jiang, Hou-Zao Chen, Yan Zhang, Song Tian, Xiao-Fei Zhang, Xiao-Dong Zhang,[...]. J Hepatol 2015
57
22

TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.
Sayaka Inokuchi-Shimizu, Eek Joong Park, Yoon Seok Roh, Ling Yang, Bi Zhang, Jingyi Song, Shuang Liang, Michael Pimienta, Koji Taniguchi, Xuefeng Wu,[...]. J Clin Invest 2014
116
22

Reprogramming Innate Immune Signaling in Cardiometabolic Disease.
Yaxing Zhang, Xiao-Jing Zhang, Pi-Xiao Wang, Peng Zhang, Hongliang Li. Hypertension 2017
19
42

Progress and challenges in the prevention and control of nonalcoholic fatty liver disease.
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Med Res Rev 2019
69
22

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease.
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Trends Endocrinol Metab 2018
44
22

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Jorge Henao-Mejia, Eran Elinav, Chengcheng Jin, Liming Hao, Wajahat Z Mehal, Till Strowig, Christoph A Thaiss, Andrew L Kau, Stephanie C Eisenbarth, Michael J Jurczak,[...]. Nature 2012
19

Liver capsule: IRFs in hepatocytes: Pathophysiology.
Pi-Xiao Wang, Xiao-Jing Zhang, Hongliang Li. Hepatology 2016
10
70

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.
Guang-Nian Zhao, Ding-Sheng Jiang, Hongliang Li. Biochim Biophys Acta 2015
130
19

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
19

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
Yaxing Zhang, Hongliang Li. Physiology (Bethesda) 2017
22
31

TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.
X-F Zhang, R Zhang, L Huang, P-X Wang, Y Zhang, D-S Jiang, L-H Zhu, S Tian, X-D Zhang, H Li. Cell Death Dis 2014
31
22


Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.
Juan-Juan Qin, Wenzhe Mao, Xiaozhan Wang, Peng Sun, Daqing Cheng, Song Tian, Xue-Yong Zhu, Ling Yang, Zan Huang, Hongliang Li. J Hepatol 2018
36
19

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.
Ke-Qiong Deng, Aibing Wang, Yan-Xiao Ji, Xiao-Jing Zhang, Jing Fang, Yan Zhang, Peng Zhang, Xi Jiang, Lu Gao, Xue-Yong Zhu,[...]. Nat Commun 2016
54
16

Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
Yan Zhang, Xiaoxiong Liu, Zhi-Gang She, Ding-Sheng Jiang, Nian Wan, Hao Xia, Xue-Hai Zhu, Xiang Wei, Xiao-Dong Zhang, Hongliang Li. Basic Res Cardiol 2014
43
16

Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Zheng Chen, Liang Sheng, Hong Shen, Yujun Zhao, Shaomeng Wang, Robert Brink, Liangyou Rui. Diabetes 2012
42
16

Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Xi Jiang, Ke-Qiong Deng, Yuxuan Luo, Ding-Sheng Jiang, Lu Gao, Xiao-Fei Zhang, Peng Zhang, Guang-Nian Zhao, Xueyong Zhu, Hongliang Li. Hypertension 2015
47
16

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
16

NF-κB, inflammation, and metabolic disease.
Rebecca G Baker, Matthew S Hayden, Sankar Ghosh. Cell Metab 2011
16

TAK1 regulates hepatic lipid homeostasis through SREBP.
S Morioka, K Sai, E Omori, Y Ikeda, K Matsumoto, J Ninomiya-Tsuji. Oncogene 2016
21
28

USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
Shimin An, Ling-Ping Zhao, Li-Jun Shen, Siyuan Wang, Kuo Zhang, Yu Qi, Jilin Zheng, Xiao-Jing Zhang, Xue-Yong Zhu, Rong Bao,[...]. Hepatology 2017
32
18

Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction.
Lang Wang, Yanyun Lu, Hongjing Guan, Dingsheng Jiang, Yu Guan, Xin Zhang, Hiroyasu Nakano, Yan Zhou, Yan Zhang, Li Yang,[...]. J Neurochem 2013
35
17

Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.
Anna Missiou, Natascha Köstlin, Nerea Varo, Philipp Rudolf, Peter Aichele, Sandra Ernst, Christian Münkel, Carina Walter, Peter Stachon, Benjamin Sommer,[...]. Circulation 2010
51
16

Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Li-Hua Zhu, Aibing Wang, Pengcheng Luo, Xinan Wang, Ding-Sheng Jiang, Wei Deng, Xiaofei Zhang, Tao Wang, Yi Liu, Lu Gao,[...]. J Hepatol 2014
41
16

Triggering and resolution of inflammation in NASH.
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E Feldstein. Nat Rev Gastroenterol Hepatol 2018
335
16

Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
Pengcheng Luo, Pi-Xiao Wang, Zuo-Zhi Li, Xiao-Jing Zhang, Xi Jiang, Jun Gong, Juan-Juan Qin, Junhong Guo, Xueyong Zhu, Sijun Yang,[...]. Am J Pathol 2016
24
25

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
Jingjing Cai, Meng Xu, Xiaojing Zhang, Hongliang Li. Annu Rev Pathol 2019
44
16

Time to step-up the fight against NAFLD.
Xiao-Jing Zhang, Zhi-Gang She, Hongliang Li. Hepatology 2018
24
25

Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity.
Zheng Chen, Mark J Canet, Liang Sheng, Lin Jiang, Yi Xiong, Lei Yin, Liangyou Rui. Mol Metab 2015
23
21

Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Yinqing Huang, Dengyin Wu, Xin Zhang, Minghua Jiang, Chaohui Hu, Jiangfeng Lin, Jifei Tang, Lianpin Wu. Gene 2014
23
21

Interferon regulatory factor 9 is critical for neointima formation following vascular injury.
Shu-Min Zhang, Li-Hua Zhu, Hou-Zao Chen, Ran Zhang, Peng Zhang, Ding-Sheng Jiang, Lu Gao, Song Tian, Lang Wang, Yan Zhang,[...]. Nat Commun 2014
52
13

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.
Ding-Sheng Jiang, Xiang Wei, Xiao-Fei Zhang, Yu Liu, Yan Zhang, Ke Chen, Lu Gao, Heng Zhou, Xue-Hai Zhu, Peter P Liu,[...]. Nat Commun 2014
111
13

TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
Li-Hua Dong, Liang Li, Yu Song, Zhi-Li Duan, Shao-Guang Sun, Yan-Ling Lin, Sui-Bing Miao, Ya-Juan Yin, Ya-Nan Shu, Huan Li,[...]. Circ Res 2015
36
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.